Mahakaal Utpad Paryavaran Jadi Booti Anusandhan Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
About Mahakaal Utpad Paryavaran Jadi Booti Anusandhan Pharmacy
Mahakaal Utpad Paryavaran Jadi Booti Anusandhan Pharmacy Private Limited (MUPJBAPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 October 2018 (Six years and four months 8 days old ). Its registered office is in Aligarh, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amar Vati, Kailash Sharma, and Maharaj Singh serve as directors at the Company.
Company Details
- Location
Aligarh, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100UP2018PTC109330
- Company No.
109330
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Oct 2018
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Mahakaal Utpad Paryavaran Jadi Booti Anusandhan Pharmacy?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amar Vati  | Director | 17-Oct-2018 | Current |
| Kailash Sharma | Director | 17-Oct-2018 | Current |
| Maharaj Singh | Director | 17-Oct-2018 | Current |
Financial Performance of Mahakaal Utpad Paryavaran Jadi Booti Anusandhan Pharmacy.
Enhance accessibility to Mahakaal Utpad Paryavaran Jadi Booti Anusandhan Pharmacy's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mahakaal Utpad Paryavaran Jadi Booti Anusandhan Pharmacy?
Unlock access to Mahakaal Utpad Paryavaran Jadi Booti Anusandhan Pharmacy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mahakaal Utpad Paryavaran Jadi Booti Anusandhan Pharmacy?
Unlock and access historical data on people associated with Mahakaal Utpad Paryavaran Jadi Booti Anusandhan Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mahakaal Utpad Paryavaran Jadi Booti Anusandhan Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mahakaal Utpad Paryavaran Jadi Booti Anusandhan Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.